AdaptHealth Corp. (AHCO) Misses Q2 EPS by 4c ; Offers Guidance

AdaptHealth Corp. (NASDAQ: AHCO) reported Q2 EPS of $0.09, $0.04 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $793.3 million versus the consensus estimate of $765.16 million.

GUIDANCE:

AdaptHealth Corp. sees FY2023 revenue of $3.16-3.2 million, versus the consensus of $3.144 million.

For earnings history and earnings-related data on AdaptHealth Corp. (AHCO) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• Utah Medical Products (UTMD) Tops Q2 EPS by 84c
• Cass Information Systems (CASS) Reports In-Line Q2 EPS